Ondansetron Solution
Product Images NDC 16714-671

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 16714-671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg/5 mL (50 mL Bottle))

This is a medication called Ondansetron Oral Solution, USP that comes in a 50 mL bottle with each 5 mL dose containing 4 mg of ondansetron hydrochloride. The package insert should be consulted for dosage and administration. It is manufactured by Aurobingo Pharma Limited in India and distributed by NortStar Healthcare Holdings for North America. It should be stored between 20°C to 25°C and protected from light. This particular bottle was revised on December 12, 2017.*

FDA Label Image

Fig2 (Ondansetron Fig2)

Each mL of oral solution contains 4 mg of Ondansetron Hydrochloride (dihydrate) USP. The usual dosage and administration information can be obtained from the package insert. Ondansetron should be stored between 20°C - 25°C (68°F - 77°F) and protected from light. The solution is limited to prescription only. The product is manufactured by Aurobindo Pharma Limited in Hyderabad, India for Northstar Rx LLC in Memphis, TN.*

FDA Label Image

Chemical Structure (Ondansetron Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.